Preclinical Data

Business

Tesla's Safety Score Under Fire: How Telematics Data Sparks Insurance Disputes and Regulatory Scrutiny

A California class-action lawsuit and regulatory actions are challenging Tesla's usage-based insurance model, alleging that its Safety Score algorithm unfairly penalizes drivers with 'false' collision warnings. The case highlights broader concerns about transparency and consumer protection in the growing telematics-driven insurance sector.

Feb 2, 2026

Business

Fact Check: Trump's Tariff Triumph Narrative Collides With Economic Data

An analysis of President Trump's recent op-ed claims reveals significant discrepancies between his portrayal of tariff success and official trade figures, price impact studies, and the nuanced reality of their implementation.

Feb 2, 2026

Business

Lexeo Therapeutics Faces Market Skepticism Despite Positive PKP2 Gene Therapy Data

H.C. Wainwright maintains a Buy rating on Lexeo Therapeutics but slashes its price target, citing persistent market doubts over the company's PKP2 cardiomyopathy program despite encouraging early clinical results.

Feb 2, 2026

Business

Nvidia's Earnings Loom: Does Timing Your Buy Before Feb. 25 Matter? Historical Data Suggests Patience

As Nvidia prepares to report its fiscal Q4 earnings on February 25th, investors are weighing whether to buy ahead of the event. While the AI chip leader's long-term story remains compelling, a look at its recent post-earnings stock performance reveals a pattern that favors a measured approach over trying to time the market.

Feb 2, 2026

Business

Markets Edge Lower Ahead of Key Labor Data, Earnings Deluge

U.S. stock futures pointed to a lower open Monday as investors braced for a flood of corporate earnings and crucial labor market reports that could sway Federal Reserve policy expectations.

Feb 2, 2026

World

Aid Groups Draw 'Red Line' at Israeli Data Demands, Vow to Stay in Gaza Despite MSF Ban

A coalition of major international NGOs is refusing to comply with Israeli orders to hand over detailed staff information, calling it a safety risk and an obstruction of aid, as tensions escalate following the expulsion of Médecins Sans Frontières.

Feb 2, 2026

Business

Bitcoin's Fate Hinges on U.S. Labor Data and MicroStrategy Earnings This Week

As Bitcoin grapples with volatility below $80,000, a packed U.S. economic calendar—featuring key jobs reports and MicroStrategy's Q4 earnings—is poised to dictate the cryptocurrency's near-term trajectory by shaping Federal Reserve policy expectations.

Feb 2, 2026

World

From Doubt to Data: How Western Narratives Initially Undermined Gaza's Death Toll

As Israel now acknowledges over 70,000 killed in Gaza, rights advocates argue that early Western political and media skepticism dehumanized Palestinians and delayed a full reckoning with the war's human cost.

Feb 2, 2026

World

Israel Moves to Expel Doctors Without Borders from Gaza Over Staff Data Dispute

The Israeli government has ordered Médecins Sans Frontières (MSF) to cease operations in Gaza by the end of February, citing the aid group's refusal to hand over details of its Palestinian staff—a move critics decry as a dangerous politicization of humanitarian aid.

Feb 2, 2026

Business

Sarepta's Gene Therapy Shows Sustained Slowing of DMD Progression in Landmark Three-Year Data

New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.

Jan 31, 2026

Business

WhiteFiber Stock in Focus After Analyst Adjustment and Major New Data Center Deal

Despite a trimmed price target from B. Riley, WhiteFiber Inc. (WYFI) secures a pivotal 10-year colocation agreement expected to generate $865 million, spotlighting its role in the expanding AI infrastructure sector.

Jan 30, 2026

Business

Palantir's AI Ambition: Can the Data Analytics Powerhouse Sustain Its Meteoric Rise?

From a $10 direct listing to a $150 S&P 500 constituent, Palantir's journey has been fueled by the AI boom. As government and commercial demand surge, analysts project staggering growth. But with sky-high valuations, the path forward requires navigating lofty expectations.

Jan 30, 2026

Business

Broadcom's AI Chip Dominance Fuels Investor Optimism Amid Data Center Boom

As demand for AI infrastructure surges, Broadcom's custom chip business positions it for sustained growth, with analysts highlighting its potential for long-term portfolio gains despite its absence from some top stock lists.

Jan 30, 2026

World

MSF Refuses Israeli Demand for Staff Data, Citing Safety Risks in Gaza

Doctors Without Borders (MSF) has definitively rejected an Israeli order to hand over sensitive staff information, following months of failed negotiations. The move comes amid a wider crackdown on aid groups and a devastating toll on healthcare workers in the conflict.

Jan 30, 2026

Business

Slovenia Taps Planet Labs for Satellite Data, as Market Weighs High-Flying Valuation

Planet Labs secures a strategic enterprise agreement with the Slovenian government, expanding its public sector footprint with applications in agriculture, urban development, and disaster preparedness. The deal comes as investors scrutinize the company's premium market valuation amidst growing competition in the Earth observation sector.

Jan 30, 2026

Business

Analysts Eye Credo Technology's AI Data Center Role, But Competition Looms

Rosenblatt Securities initiates coverage on Credo Technology with a Neutral rating and a $170 price target, highlighting its strong position in high-speed connectivity for AI infrastructure while flagging competitive pressures. The note follows a more bullish target hike from Barclays earlier in the month.

Jan 30, 2026

Business

Equifax Bets on AI and Verified Data to Deepen Its Moat, But Can It Justify the Premium?

Equifax is expanding beyond traditional credit reporting with a new suite of AI-powered fraud detection and income verification tools. While this strategic push aims to embed the company deeper into the lending ecosystem, analysts remain divided on whether it's enough to support its current valuation amid high debt and execution risks.

Jan 30, 2026

Business

Analysts Bullish on Riot Platforms After Strategic AMD Data Center Deal

Keefe Bruyette & Woods raises its price target on Riot Platforms (RIOT) to $23, citing a new long-term agreement with AMD that provides revenue visibility and supports the company's high-performance computing strategy.

Jan 30, 2026

Business

Mineralys Therapeutics Submits New Drug Application for Hypertension Treatment Lorundrostat, Backed by Strong Clinical Data

Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.

Jan 30, 2026

Business

AI Data Surge Fuels Western Digital's Strong Q2, Drives High-Capacity Storage Demand

Western Digital's fiscal Q2 2026 results showcase robust growth, with revenue climbing 25% year-over-year to $3.0 billion. The company credits accelerating AI adoption for driving demand for its high-capacity nearline hard drives and advanced technologies like HAMR and UltraSMR.

Jan 30, 2026